In focus
Latest feed
The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s
The Pharmaceutical Frontier: Biosimilars on the Rise
A Game Changer for Canadians? Dr. Reddy's Unveils Generic Semaglutide Injection
A New Dawn for High-Tech Manufacturing: KJS India's Second Unit Breaks Ground in Telangana
